Conference Highlights: RSNA 2010 | Conference Coverage

RSNA 2010, the annual meeting of the Radiological Society of North America, was held from November 29 to December 3 in Chicago. The features below highlight just

Good Nutrition Critical to Chemotherapy | Opinion Article

Targeted therapies and advances in genetics are enabling more personalized patient care for several cancer types. However, treating cancer patients goes beyond the cancer itself; clinicians need to treat the whole patient. Nutrition is an often overlooked element of care.

Conference Highlights: CHEST 2010 | Conference Coverage

The CHEST 2010 annual meeting offers clinical instruction in pulmonary, critical care, and sleep medicine. These features include research presented on diabetes drugs fighting lung cancer progression,

Could New Blood Test Detect Cancer? | Medical Blog

A blood test that could revolutionize the way doctors detect and treat cancer is one step closer to becoming available. Johnson & Johnson has teamed up with

Eat Your Sweet Potatoes This Thanksgiving and Live Longer! | Medical Blog

A large study just released by the CDC found that consumption of high levels of alpha carotene appears to reduce the risk of dying of all causes

Conference Highlights: ICAAC Annual Meeting | Conference Coverage

The 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, or ICAAC, held its 2010 annual meeting from September 12 to 15 in Boston. Among the news emerging

Raising Awareness on Breakthrough Cancer Pain | Feature

Breakthrough cancer pain is highly prevalent, but providers can take steps to reduce the disease burden and offer treatments that may improve outcomes.

CRC Surveillance in Patients With IBD | Opinion Article

Certain patients with inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn’s disease of the colon, have an increased risk of developing colorectal cancer (CRC).

Updated Practice Guidelines for Ovarian Cancer | Feature

Revised guidelines issued by the National Comprehensive Cancer Network on ovarian cancer address key issues in disease management, including allergic reactions to chemotherapy agents and new agents for recurrence therapy.

Rapid Desensitization for Chemotherapy Allergies | Opinion Article

There has been much research over the past 5 years into the development of approaches for desensitizing patients who are allergic to the chemotherapy regimens they need.

Smoking Rates at a Standstill | Opinion Article

Smoking rates in the United States continue to stay at about 1 in 5 adults, according to health officials on Tuesday. Although smoking rates in this country have

Updating Hepatocellular Carcinoma Trends | Feature

New data demonstrate that hepatocellular carcinoma (HCC) incidence rates have increased dramatically since the 1970s, but survival rates in HCC are improving. Better surveillance of high-risk patients is critical.

Preventing Delayed CINV to Improve Patient Outcomes | Feature

CINV, particularly delayed-onset CINV, is a significant adverse effect of chemotherapy, but prophylactic medications are available to effectively prevent the problem in many patients receiving treatment for their cancer.

Overcoming the Oncology Workforce Shortage | Opinion Article

In March 2007, results of a study commissioned by the American Society of Clinical Oncology (ASCO) Board of Directors on supply and demand for oncology services through

New Initiatives to Improve Patient Care | Opinion Article

Nurses have the opportunity to make valuable contributions to the growing community of cancer patients who are actively in treatment and those who have survived it. It’s

A Smoking Cessation Strategy for Thoracic Surgeons | Opinion Article

Tobacco use is the leading cause of preventable morbidity and mortality in the United States, and almost 90% of all lung cancers are caused by smoking tobacco.

New Guidelines for Advanced NSCLC | Opinion Article

In 1997, the American Society of Clinical Oncology (ASCO) released its first guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). Since then, new research and FDA-approved treatments have changed management strategies for stage IV NSCLC. In the November 23, 2009 Journal of Clinical Oncology, ASCO updated its treatment recommendations for using chemotherapy for stage IV disease.

American Society of Clinical Oncology 2010 | Conference Coverage

The American Society of Clinical Oncology, or ASCO, held its 2010 annual meeting from June 4 to 8 in Chicago. The features below highlight some of the

Catching the Warning Signs of DVT | Conference Coverage

In the United States, more people die each year from pulmonary embolism (PE) than motor vehicle accidents, breast cancer, or AIDS. Most PEs are complications of deep

Redefining Screening Guidelines for Certain Cancers | Feature

The University of Texas MD Anderson Cancer Center has released comprehensive, risk-based screening guidelines for breast, cervical, and colorectal cancer, highlighting important new evidence to guide practices.

Page 27 of 28« First...2425262728